Literature DB >> 24991361

Rapid expansion of new oncology care delivery payment models: results from a payer survey.

Rhonda Greenapple1.   

Abstract

BACKGROUND: Oncology practices are seeking to adapt to new care delivery models, including accountable care organizations (ACOs), patient-centered medical homes (PCMHs) in oncology, and oncology pathways, as well as new payment models, such as bundled payments or pay-for-performance contracts.
OBJECTIVE: Our survey sought to determine which payment models and care delivery models payers view as the most viable and the most potentially impactful in managing and reducing the cost of cancer care.
METHODS: We conducted an online national survey of 49 payers, including 19 medical directors and 30 pharmacy directors, representing more than 100 million covered lives within national and regional plans, using a validated instrument comprised of approximately 120 questions. The survey was administered using the SurveyGizmo website. It was initiated on July 10, 2012, and completed on July 25, 2012. The survey included open- and closed-ended questions and probed payers about models of care that they, in collaboration with providers, are implementing or supporting to improve the quality of cancer care and to reduce the associated costs.
RESULTS: Payers are rapidly moving to implement new reimbursement models to support new care delivery models, including ACOs and PCMHs. Based on the results of this survey, a minority of payers are experimenting with new oncology payment models, but most payers are evaluating various models, including bundled payments, capitation, shared savings, and pay for performance. Of the payers in this survey, 39% have already implemented oncology pathways, and 59% who have not already done so are planning to implement pathways in 2 years. Input from local oncology experts is an important resource for pathway development, and a substantial majority (95%) of payers will use pathways to address earlier initiation of palliative care discussions where appropriate.
CONCLUSION: Payers anticipate that there will be a rapid expansion of the use of innovative approaches to oncology cost management over the next 2 years. As payers and their network providers gain more experience in collaborative care delivery, it is expected that demonstration of cost-savings will become more robust and convincing, and a variety of approaches will become more widely adopted.

Entities:  

Year:  2013        PMID: 24991361      PMCID: PMC4031716     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  5 in total

1.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Authors:  Bruce L Jacobs; Yun Zhang; Florian R Schroeck; Ted A Skolarus; John T Wei; James E Montie; Scott M Gilbert; Seth A Strope; Rodney L Dunn; David C Miller; Brent K Hollenbeck
Journal:  JAMA       Date:  2013-06-26       Impact factor: 56.272

2.  American society of clinical oncology statement: toward individualized care for patients with advanced cancer.

Authors:  Jeffrey M Peppercorn; Thomas J Smith; Paul R Helft; David J Debono; Scott R Berry; Dana S Wollins; Daniel M Hayes; Jamie H Von Roenn; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

3.  Where does oncology fit in the scheme of accountable care?

Authors:  Ronald Barkley
Journal:  J Oncol Pract       Date:  2012-03       Impact factor: 3.840

4.  Oncology patient-centered medical home.

Authors:  John D Sprandio
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

5.  Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.

Authors:  Bruce A Feinberg; James Lang; James Grzegorczyk; Donna Stark; Thomas Rybarczyk; Thomas Leyden; Joseph Cooper; Thomas Ruane; Scott Milligan; Phillip Stella; Jeffrey A Scott
Journal:  Am J Manag Care       Date:  2012-05-01       Impact factor: 2.229

  5 in total
  3 in total

Review 1.  Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services.

Authors:  Julie K Silver; Vishwa S Raj; Jack B Fu; Eric M Wisotzky; Sean Robinson Smith; Rebecca A Kirch
Journal:  Support Care Cancer       Date:  2015-08-28       Impact factor: 3.603

Review 2.  Linking Quality and Spending to Measure Value for People with Serious Illness.

Authors:  Andrew M Ryan; Phillip E Rodgers
Journal:  J Palliat Med       Date:  2017-11-01       Impact factor: 2.947

3.  Impact of oncologist payment method on health care outcomes, costs, quality: a rapid review.

Authors:  Emily McPherson; Lindsay Hedden; Dean A Regier
Journal:  Syst Rev       Date:  2016-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.